Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Cariprazine in Acute Mania
NCT07665073Phase 4Not yet recruiting
- Sponsor
- Pakistan Institute of Medical Sciences
- Start
- Jun 2027
- Primary completion
- Jun 2028
01
Overview
A Phase 4 trial of risperidone in bipolar I disorder, sponsored by Pakistan Institute of Medical Sciences. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
risperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT07665073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07665073.